Pfizer-ka ayaa ku habanaya balaayiin doolar nooc cusub oo kansarka ah Immurapy-ga Immunotherap, oo oggolaanaya Isniinta in la shatiro nooc duawo ah oo loo soo ifbaxay in ay tahay in dawooyin ku sugan yahay oncology-ka.
Biophaceutical R & D wuxuu wajahayaa cadaadis ka badan sidii hore. Shirkadaha ayaa la filayaa inay dardar geliyaan xawaaraha hal abuurka, yaree waqtiga horumarinta, iyo xakameynta qiimaha buufinta - dhammaantood inta ay soconayaan sayniska adag ee sii kordhaya. Maanta, waa kan
Marka loo eego baahiyadeena, shirkaddu waxay bixisay talobixin xirfadeed iyo hagitaan oo bilaash ah si ay nooga caawiso sidii aan u dooran lahaa xalka saxda ah.